USFDA gives nod to Alembic for this generic solution for Inhalation

This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies Private Limited.

208
USFDA Approval
USFDA Approval

Last Updated on October 15, 2024 by The Health Master

Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for arformoterol tartrate inhalation solution, 15 mcg (base)/2 mL Unit-dose Vial.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Brovana inhalation solution, 15 mcg/2 mL, of Sunovion Pharmaceuticals Inc.

Arformoterol tartarate inhalation solution is a long-acting beta2-adrenergic agonist (beta2-agonist) indicated for long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies Private Limited.

Arformoterol tartrate inhalation solution, 15 mcg (base)/2 mL Unit-dose vial, has an estimated market size of US$ 251 million for twelve months ending December 2021 according to IQVIA.

Alembic has a cumulative total of 167 ANDA approvals (143 final approvals and 24 tentative approvals) from US FDA, including this second inhalational ANDA approval.

Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world.

USFDA gives tentative nod to Glenmark for Calcipotriene and Betamethasone Dipropionate foam

USFDA gives tentative approval for this Hypertension drug

USFDA gives tentative nod to Zydus for Selexipag tablets

USFDA gives approval to Lupin Pregabalin capsules

USFDA gives final approval to Aleor Dermaceuticals for Docosanol cream

USFDA gives nod to these companies for Bortezomib for injection

USFDA gives 10 observations to Sun Pharm

CDSCO extends timeline for importing of drugs with shelf life less than 60%

FAQs – on Blood Bags and its Testing

USFDA gives tentative nod to Glenmark for Calcipotriene and Betamethasone Dipropionate foam

IPC releases IP 2022, 92 new monograph, 27 APIs added: Read details

USFDA gives tentative approval for this Hypertension drug

Man held in Internet pharmacy racket, Rs 3.17 cr cash seized

Man gets 10-years rigorous imprisonment for making drugs illegally

USFDA gives tentative nod to Zydus for Selexipag tablets

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news